For BFL1, we previously reported that there was no significant overall increase in BFL1 mRNA in DLBCL patient samples compared to normal B-cells, but a fraction of DLBCL samples did overexpress BFL1 [47]. This evidence concerns the gene BCL2A1 and diffuse large B-cell lymphoma.